This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molina Healthcare to Buy Affinity Health Plan for $380 Million
by Zacks Equity Research
Molina Healthcare (MOH) to purchase Affinity Health Plan's assets to boost its capabilities and enhance its portfolio in the process.
Humana Ties Up to Provide Improved Medical Care in Ohio
by Zacks Equity Research
Humana (HUM) partners The Ohio State University Wexner Medical Center to provide in-network healthcare for Humana Medicare Advantage members.
Uncertainty Over Supreme Court Ruling Weighs on Healthcare
by Zacks Equity Research
Health insurers and hospital stocks depreciate after Justice Ruth Bader Ginsburg who defended the Obamacare breathes her last.
Humana (HUM) Ties Up to Boost Medicare Network in New Jersey
by Zacks Equity Research
Humana (HUM) forges partnership with AtlantiCare to enhance its presence in New Jersey as well as provide better healthcare to its members.
Here's Why You Should Hold Magellan Stock in Your Portfolio
by Zacks Equity Research
Magellan (MGLN) continues to benefit from cost-cutting initiatives and impressive capital position.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
Molina (MOH) Down 1.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
by Zacks Equity Research
Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on an upbeat outlook and rising membership, Anthem (ANTM) holds immense potential to reap benefits for investors.
Solid Near-Term HMO Industry Prospects on Multiple Tailwinds
by Sapna Bagaria
Health insurers are on a solid ground, given rising demand for Medicare policies, led by the increasing baby boomer population.
3 Health Insurers That Surpass the S&P 500 Year to Date
by Srijita Guha
We zero in on three health insurers that have managed to outperform the broader index year to date, banking on core strength.
Molina Healthcare (MOH) Surges 44.1% YTD: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) rising membership is likely to boost its revenues, which in turn, might perk up in share price.
Cigna Banks on Diversified Business, Solid Capital Position
by Zacks Equity Research
Cigna's (CI) prolific business profile creates a steady revenue recovery trajectory while its solid financial footing enables reinvestment in business
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 results reflect higher revenues and membership growth.
Molina (MOH) Tops Q2 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 1.92% and -1.74%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Cigna (CI) Keep the Beat Streak Alive in Q2 Earnings?
by Zacks Equity Research
Cigna's (CI) business is likely to have been weighed down in Q2 due to high unemployment rate, partly offset by the delay in elective procedures resulting in lower claims.
Centene's (CNC) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Centene's (CNC) second-quarter results reflect robust revenues.
5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus
by Zacks Equity Research
Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.
Anthem (ANTM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) second-quarter results are likely to reflect impressive revenues and rising membership.
What's in the Cards for Centene's (CNC) Q2 Earnings?
by Zacks Equity Research
Centene's (CNC) Q2 results are likely to reflect better revenues, partly offset by the COVID-19 impact.
Universal Health (UHS) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Universal Health's (UHS) second-quarter results are likely to reflect muted revenues.
Molina (MOH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare's (HCA) Q2 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect lower expenses, partly offset by a decline in admissions.
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare's Buyout Deal to Boost Its Base in Kentucky
by Zacks Equity Research
Molina Healthcare's (MOH) upcoming acquisition will fortify its presence in the Kentucky market.